Canaccord Genuity Maintains a 'Buy' on Dendreon (DNDN); CMS Draft Decision Expcted to Weigh Favorably

March 29, 2011 10:01 AM EDT Send to a Friend
Canaccord Genuity maintains a 'Buy' on Dendreon (NASDAQ: DNDN), PT $65.
Canaccord analyst says , "We are buyers of DNDN ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login